Showing 1 - 2 results of 2 for search 'C. D. DiNardo', query time: 0.03s
Refine Results
-
1
P581: PHASE II STUDY OF LOWER-INTENSITY FRONTLINE THERAPY FOR NEWLY DIAGNOSED PATIENTS WITH AML WHO ARE UNFIT OR OTHERWISE NOT ELIGIBLE FOR FRONTLINE CLINICAL TRIALS by S. Venugopal, E. Jabbour, N. Pemmaraju, G. Montalban-Bravo, K. S. Chien, N. Daver, N. Jain, J. Burger, Y. Alvarado, A. Maiti, C. D. DiNardo, G. Borthakur, R. Malla, G. Garcia-Manero, F. Ravandi, H. Kantarjian, T. Kadia
Published 2022-06-01
Article -
2
P765: UPDATED ENROLLMENT AND RESULTS FROM THE PHASE 1 SUBSTUDY OF IVOSIDENIB IN PATIENTS WITH IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME (R/R MDS) by C. D. DiNardo, J. M. Foran, J. M. Watts, E. M. Stein, S. de Botton, A. T. Fathi, G. T. Prince, R. M. Stone, P. A. Patel, G. J. Roboz, M. L. Arellano, H. P. Erba, A. Pigneux, P. Baratam, R. K. Stuart, X. Thomas, I. R. Lemieux, X. Bai, S. M. Kapsalis, G. Garcia-Manero, D. A. Sallman
Published 2022-06-01
Article